MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Ask AI
All specialtiesCardiologyOncologyRespiratoryDiabetes & EndocrinologyNeurology
More specialties
newsClinical UpdatesPublic HealthGastroenterologyHematology-OncologyPediatricsInternal MedicineFamily Medicine & NutritionPsychiatryGeneral SurgeryOB/GYN & Women's HealthCritical CareInfectious DiseasesOtorhinolaryngologyOphthalmologyRadiologyNephrologySuperintelligenceOB/GYN & Women’s HealthDermatologyEmergency MedicineMedical NewsRheumatologyOrthopedicsUrologyAllergy & ImmunologyPlastic SurgeryPathology & Lab MedicineAnesthesiologyNursing & careRehabilitation MedicinePathology & Lab Medicine/Bệnh họcTransplantationDentistryHIV/AIDS

The clinical briefing

Medical news

8,171 articles

Latest updates

Critical Care

Evaluating Cluster vs. Individual Randomization in Acute Care Trials: Insights from a Meta-Epidemiological Study

This study examines differences in effect estimates between cluster-randomized and individually randomized clinical trials in prehospital, emergency, and critical care, revealing systematic bias in length-of-stay outcomes but not mortality.

Nov 4, 2026
Cardiology

Anticoagulation in Octogenarians with Atrial Fibrillation: Balancing Mortality Benefits and Bleeding Risks

Anticoagulation therapy in adults aged 80 and older with atrial fibrillation is linked to reduced all-cause mortality despite an increased risk of gastrointestinal bleeding, supporting its continued use in selected elderly patients.

Nov 4, 2026
Allergy & Immunology

Navigating Autoimmune Neutropenia in Adults: Diagnosis and Tailored Treatment Strategies

Autoimmune neutropenia (AiN) in adults, though rare, is a chronic condition predominantly affecting women with autoimmune comorbidities. Treatment prioritizes observation, with therapies aimed at boosting neutrophil counts or modulating imm

Nov 4, 2026
Respiratory

Unraveling Mild-to-Moderate COPD: Distinct Phenotypes and Prognostic Diversity from a Community Cohort Study

This study reveals heterogeneous clinical phenotypes in mild-to-moderate COPD, demonstrating significant variability in exacerbation risk and lung function decline, emphasizing precision medicine for early intervention.

Nov 4, 2026
Ophthalmology

Enhancing Deep Sclerectomy Outcomes: Autologous Anterior Lens Capsule as an Effective Intrascleral Spacer

A randomized trial demonstrates that using an autologous anterior lens capsule as an intrascleral spacer during deep sclerectomy combined with phacoemulsification lowers intraocular pressure and enhances surgical success in glaucoma patient

Nov 4, 2026
Gastroenterology

Days at Home After Gastrointestinal Cancer Surgery: Validating a Patient-Centered Outcome Metric

This review synthesizes evidence establishing Days at Home within 90 days (DAH-90) after gastrointestinal cancer surgery as a valid, meaningful patient-centered outcome, integrating survival, morbidity, and healthcare utilization to optimiz

Nov 4, 2026
Hematology-Oncology

Estimating the National Impact of Severe Hemolytic Disease of the Fetus and Newborn in the United States

A large-scale analysis estimates the U.S. national burden of severe hemolytic disease of the fetus and newborn (HDFN) caused by anti-D, anti-K, and anti-c alloantibodies, revealing that severe HDFN is rare despite common alloimmunization.

Nov 4, 2026
Oncology

Derazantinib in FGFR2-Altered Intrahepatic Cholangiocarcinoma: Promising Phase 2 Efficacy with Manageable Toxicity

A pivotal Phase 2 study demonstrates that derazantinib yields meaningful responses and progression-free survival in FGFR2-aberrant advanced intrahepatic cholangiocarcinoma, with an acceptable safety profile, supporting its role as a targete

Nov 4, 2026
Neurology

Unraveling SPDMLS: Gain-of-Function PLAAT4 Variants in Spinal Predominant Demyelinating Leukodystrophy

Gain-of-function variants in PLAAT4 define a novel autosomal dominant leukodystrophy characterized by spastic paraplegia and spinal cord white matter abnormalities, with arachidonic acid-related lipids as potential biomarkers.

Nov 4, 2026
Diabetes & Endocrinology

Acmopatide Shows Promising Glycemic and Weight Control in Overweight Adults with Type 1 Diabetes: Phase 2 Trial Results

Acmopatide, a novel biased GLP-1/GIP receptor agonist, improves glycemic control and reduces body weight without severe adverse events in overweight adults with type 1 diabetes, based on a 16-week phase 2 randomized trial.

Nov 4, 2026
Cardiology

Impact of Subtypes and Ventriculocoronary Connections on Hypoplastic Left Heart Syndrome Outcomes: Insights from the Fetal Heart Society Multicenter Study

This multicenter study reveals that among HLHS subtypes, mitral stenosis and aortic atresia with ventriculocoronary connections have the poorest transplant-free survival, highlighting the prognostic importance of prenatal and postnatal VCC

Nov 4, 2026
Orthopedics

Optimizing Platelet-Rich Plasma Therapy in Early Knee Osteoarthritis: A Multicenter Randomized Trial of a Standardized Clinical Pathway

A multicenter RCT demonstrates that a standardized clinical pathway for platelet-rich plasma therapy improves 12-month pain and function outcomes with fewer adverse events in early knee osteoarthritis compared to conventional care.

Nov 4, 2026
Dentistry

Reevaluating Oral Health Priorities for Dependent Older Adults: Insights from Multi-Stakeholder Perspectives

This study explores diverse stakeholder views on oral health needs and care for dependent older adults, highlighting the importance of subjective outcomes like comfort and function often overlooked in service provision and research.

Nov 4, 2026
Oncology

Tarlatamab Plus Durvalumab as Maintenance Therapy in Extensive-Stage Small-Cell Lung Cancer: A Breakthrough in Survival Outcomes

This phase 3 trial shows that tarlatamab combined with durvalumab significantly improves overall and progression-free survival compared to durvalumab alone as maintenance therapy post-first-line chemoimmunotherapy in extensive-stage small-c

Nov 4, 2026
Neurology

Exercise as a Cognitive Buffer in Midlife Women: Insights into Domain-Specific Effects and Modality Differences

Regular exercise in midlife women moderates age-related cognitive decline, particularly in processing speed and demanding working memory tasks, with resistance training showing unique benefits for reaction time.

Nov 3, 2026
Neurology

Empowering Safer Mobility Behaviors to Prevent Falls in Parkinson’s Disease: Insights from Clinicians and Researchers

This qualitative study reveals empowerment as central to promoting safer mobility in Parkinson’s disease, emphasizing individualized, contextual, and collaborative strategies for fall prevention.

Nov 3, 2026
Dentistry

Eating Difficulty as a Marker for Broader Functional Vulnerability and Cognitive Decline in Older Adults: Insights from Four Large Ageing Cohorts

Eating difficulty is associated with broader functional vulnerability and cognitive decline, rather than directly triggering dementia, highlighting its importance in comprehensive geriatric assessment beyond dental health screening.

Nov 3, 2026
Oncology

Izalontamab Brengitecan Shows Promising Efficacy Over Platinum Chemotherapy in EGFR-Mutated NSCLC Post-Third-Generation EGFR TKI Progression

The PANKU-Lung01 phase 3 trial demonstrates izalontamab brengitecan significantly extends progression-free survival compared to platinum-based chemotherapy in EGFR-mutated advanced non-squamous NSCLC after failure of third-generation EGFR T

Nov 3, 2026
Pediatrics

Longitudinal Executive Function Development in Very Preterm Children: Persistent Challenges into Adolescence

This study tracks executive function trajectories from age 2 to 13 in very preterm children, revealing enduring difficulties compared to full-term peers and highlighting the need for early and ongoing interventions, particularly accounting

Nov 3, 2026
Rheumatology

Unveiling the Role of CCL20+ Macrophages as TNF Producers in Axial Spondyloarthritis Synovium: Implications for Targeted Therapy

This study identifies a CCL20+ macrophage subpopulation as a major source of TNF in axial spondyloarthritis synovium, driven by CD40L and an IL-1β/TNF-α autocrine loop, providing insights into disease pathogenesis and therapeutic targets.

Nov 3, 2026
Previous
4 / 25
123456…25
Next

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.